Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Online First

August 12, 2022

Original research
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years

Alessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini, Angelora Di Risio

doi: 10.1136/ejhpharm-2022-003338

August 08, 2022

Original research
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients

QiaoWei Yang, Yan Hu, XuanLing Zhang, XiaoMin Zhang, Haibin Dai, Xingang Li

doi: 10.1136/ejhpharm-2022-003357

July 26, 2022

Short report
Factors influencing accuracy when preparing injectable drug concentrations in appliance with clinical practice: a norepinephrine case study

Sixtine Gilliot, Anthony Martin Mena, Stéphanie Genay, Morgane Masse, Manon Thibaut, Natacha Carta, Damien Lannoy, Laura Négrier, Christine Barthélémy, Bertrand Décaudin, Pascal Odou

doi: 10.1136/ejhpharm-2022-003358
Original research
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials

Mona Abdel-Tawab, Markus Waßmuth, Florian Gegenfurtner, Andrea Hawe, Jan H Schefe, Anke M Strunz, Joachim Wübert

doi: 10.1136/ejhpharm-2021-003198
Original research
Real-world effectiveness and durability of dual antiretroviral therapy in HIV-infected patients

Laia Pérez-Cordón, Azhara Sánchez, Sergio Marin, Lluis Force, Mateu Serra-Prat, Elisabet Palomera, Lluis Campins

doi: 10.1136/ejhpharm-2022-003277

July 19, 2022

Original research
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study

David Young, Fraser Cummings, Susan Latter

doi: 10.1136/ejhpharm-2022-003371
Letter
Defining a new term: defensive hospital pharmacy practices

Laura Villaverde Piñeiro, Ana Isabel Cachafeiro Pin

doi: 10.1136/ejhpharm-2022-003465
Letter
The geriatric clinical pharmacist at the emergency department: a novel front-door transdisciplinary care model

Tingting Selina Cheong, Birong Zhu, Edward Chong

doi: 10.1136/ejhpharm-2022-003458

July 07, 2022

Letter
Thoughts on the shortage of vinflunine: could we have done more?

Ana Isabel Cachafeiro Pin, Laura Villaverde Piñeiro, Yveth Michelle Tajes Gonzalez, Natalia Fernandez Nuñez

doi: 10.1136/ejhpharm-2022-003443

July 06, 2022

Original research
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document

Fekade Bruck Sime, Steven Wallis, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Jason Roberts on behalf of the BSAC Drug Stability Testing Programme

doi: 10.1136/ejhpharm-2022-003286

June 22, 2022

Original research
Transition to adult services: the current and potential role of the UK hospital pharmacist

Ashifa Trivedi, Sarah Mohamad, Sadhna Sharma, Jaikumar Ganapathi, Annika Adodra, Anne-Lise Goddings

doi: 10.1136/ejhpharm-2022-003254
Original research
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study

Stephanie Heinemann, Jonas Klemperer, Eva Hummers, Roland Nau, Wolfgang Himmel

doi: 10.1136/ejhpharm-2021-003097

June 21, 2022

Original research
Determination of plasma uracil as a screening for dihydropyrimidine dehydrogenase deficiency: clinical application in oncological treatments

Eduardo Tejedor-Tejada, Daniel Rubio Calvo, Antonio García Andreo

doi: 10.1136/ejhpharm-2021-003210
Original research
Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis

Leo Tsui, Peiying Ye, Shiling Xu, Yuan Lin, Bin Chen, Sy-Ping Chen, Ruoh-Yi Cheng

doi: 10.1136/ejhpharm-2022-003333
Original research
Factors associated with potential drug–drug interactions in psychiatric inpatients

Anica Ranković, Iva Milentijevic, Slobodan Jankovic

doi: 10.1136/ejhpharm-2022-003262

June 15, 2022

Case report
Penicillin allergy that persisted after 66 years: case report

Evon Anukam, Jenny Zhu

doi: 10.1136/ejhpharm-2022-003293

June 09, 2022

Letter
A risk prediction model of linezolid-induced thrombocytopenia for elderly patients with chronic kidney disease is urgently needed

Xiaohua Zhou, Hongjian Ji

doi: 10.1136/ejhpharm-2022-003370

June 02, 2022

Original research
The role of clinical trials in the sustainability of the Italian national health service cancer drug expenditure

Lorenzo Gasperoni, Alessandro Cafaro, Eleonora Ferretti, Valentina Di Iorio, Oriana Nanni, Carla Masini

doi: 10.1136/ejhpharm-2022-003297

May 23, 2022

Original research
Frequency of measuring body weight in (sub)populations of patients with cancer treated with chemotherapy

Shirley Kemps, Mostafa Soleyman, Harmen Huls, Mariette Labots, Mirjam Crul

doi: 10.1136/ejhpharm-2021-003215

May 19, 2022

Original research
Classification of non-antineoplastic intravenously administered drugs according to their toxicity risk: the path towards safe drug administration

Teresa Giménez Poderós, Juan José Fernández Cabero, Marta Valero Domínguez

doi: 10.1136/ejhpharm-2022-003294
Hands on medicines information
Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge?

Julie Hias, Laura Hellemans, Karolien Walgraeve, Jos Tournoy, Christophe Vandenbriele, Lucas Van Aelst, Lorenz Roger Van der Linden

doi: 10.1136/ejhpharm-2022-003305

May 06, 2022

Original research
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients

Yan Qin, Zhe Chen, Shuai Gao, Yun Shen, Yanrong Ye

doi: 10.1136/ejhpharm-2022-003258
Original research
Development and implementation of medication-related clinical rules for obstetrics, gynaecology, and paediatric outpatients

Quanyao Chen, Luwei Wang, Min Lin, Weida Chen, Wen Wu, Yao Chen

doi: 10.1136/ejhpharm-2021-003170
Original research
Comparison of the 22nd World Health Organization Model List of Essential Medicines with the explicit criteria for the treatment of chronicity in elderly patients

Ramon Fernández Fernández, Queralt Moreno Gil, Cécile Bessat, Pablo Roman, Daniel Sevilla-Sanchez

doi: 10.1136/ejhpharm-2022-003237

May 02, 2022

Letter
An antidote network in Spain, a tool to improve antidote availability in hospitals

Raquel Aguilar-Salmerón, Maria Angels Gispert-Ametller, Edurne Fernández de Gamarra-Martínez, Lídia Martínez-Sánchez, Milagros García-Peláez, Núria Pi-Sala, Emilio Salgado-García, Santiago Nogué-Xarau

doi: 10.1136/ejhpharm-2022-003328
Original research
Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France

Céline Vaesken, Paul Besnier, Claire Bernardeau, Rachid Garmi, Mélanie Malherbe, Audrey Mouet, Jocelyn Michon, Alexandra Muzard, Christophe Isnard, Isaline Bazin, Guillaume Saint-Lorant

doi: 10.1136/ejhpharm-2021-003100

April 20, 2022

Original research
Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results
Free

Mayte Gil-Candel, Antonio Solana-Altabella, Esther Vicente-Escrig, Aarón Puplá-Bartoll, Julia Bodega Azuara, Pablo Pérez-Huertas, Raul Ferrando Piqueres

doi: 10.1136/ejhpharm-2021-003194

April 15, 2022

Original research
A qualitative evaluation of weekly reflective practice sessions for the intensive care unit pharmacy team during the COVID-19 pandemic
Free

Naima Fowlis, Nina Barnett, Sara Banks, Barry Jubraj

doi: 10.1136/ejhpharm-2021-003164

April 12, 2022

Original research
Development and Delphi validation of a Best Possible Medication History form

Camille Hoornaert, Stéphanie Pochet, Sophie Lorent

doi: 10.1136/ejhpharm-2021-003095

April 11, 2022

Original research
Integrity performance assessment of a closed system transfer device syringe adaptor lock as a terminal closure for Luer-Lock syringes

Alan Shaun Wilkinson, Kate E Walker, Laima Ozolina, Romana Machníková, Andrew J Johnson, Navneet Bhogal, Kate Pegg

doi: 10.1136/ejhpharm-2021-003148
Original research
A pharmacovigilance study on antiepileptic medications in a paediatric hospital in Italy

Nicoletta Monti Guarnieri, Adriana Pompilio, Carla Marini, Giovanni Battista Ortenzi, Emanuela Andresciani, Angela Maria Felicita Garzone, Maria Consuelo Ieracitano, Carlo Polidori

doi: 10.1136/ejhpharm-2021-003053

April 05, 2022

Original research
Predictive value of immune-related adverse events during pembrolizumab treatment in non-small cell lung cancer

Carmen Maria Valencia Soto, María Victoria Villacañas Palomares, Adela Garcia-Avello Fernández-Cueto, Sara Barbadillo Villanueva, Virginia Martínez Callejo, María Ochagavía Sufrategui, Pedro Muñoz Cacho, Marta Valero Domínguez

doi: 10.1136/ejhpharm-2021-003038

March 31, 2022

Original research
Impact of a pharmaceutical intervention on influenza vaccination in patients receiving treatment with biological medicines

Laura Villaverde Piñeiro, Ana Isabel Cachafeiro Pin, Yveth Michelle Tajes González, Pilar Neira Blanco, Lorena Arias Fernández, Mónica Vázquez López, Andrés Blanco Hortas, Concepcion Castro Rubiños, José Vicente Aparici Bolufer

doi: 10.1136/ejhpharm-2021-003175

March 30, 2022

Short report
Analysis of clinical enquiries received by five COVID-19 vaccination centres in the UK
Free

Sukhpreet Bassi, Rubena Begum, Raliat Onatade, Catherine Olie

doi: 10.1136/ejhpharm-2021-003172
Short report
Analysing electronic prescribing data to detect potential undocumented adverse reactions to medications

Ben Logan, Andrew Hill

doi: 10.1136/ejhpharm-2021-003087

March 24, 2022

Original research
Analysis of adverse drug events as a way to improve cancer patient care

Noelia Vicente-Oliveros, Teresa Gramage-Caro, Elena Corral de la Fuente, Eva Delgado-Silveira, Ana María Álvarez-Díaz

doi: 10.1136/ejhpharm-2021-003199

March 10, 2022

Letter
The PEPSIN project: design and validation of a self-administered questionnaire for the assessment of equivalence between pens and prefilled syringes in patients on subcutaneous biological drugs

Lisa Pivato, C Battistutta, Federica Torni, Daniele Mengato, Francesca Temporin, Francesca Venturini

doi: 10.1136/ejhpharm-2022-003273
Original research
Factors affecting voriconazole concentration to dose ratio changes according to route of administration

Chunyan Chen, Tao Xu, Keting Zhou, Suyan Zhu

doi: 10.1136/ejhpharm-2021-003173
Letter
Automated preparation of cytotoxic drugs: the evidence for an interface between the robot and computerized provider order entry?

Romain-Pacôme Desmaris, Mathilde Roche, Assia Mitha, Sabine Azam, Vincent Blazy, Andre Rieutord, Hail Aboudagga

doi: 10.1136/ejhpharm-2022-003234

March 01, 2022

Case report
Pancytopenia in a patient treated with fusidic acid and niraparib: a case report

Margaux Damerval, Fernando Bazan, Selim Omrani, Marion Hugues, Marie-Françoise Roux, Joséphine Mayer

doi: 10.1136/ejhpharm-2021-002819

February 28, 2022

Original research
Improvement in RAID questionnaire results in patients with rheumatoid arthritis treated with advanced therapies

Andrea Rodríguez Esquíroz, Amaya Arrondo Velasco, Amaia Egüés Lugea, Maite Sarobe Carricas

doi: 10.1136/ejhpharm-2021-003084

February 25, 2022

Original research
Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBD

Jessica Gadsby, Karen Hall, Fathima Shah, Sanjeev Pattni, Sharon Gethins, Hussain Mulla

doi: 10.1136/ejhpharm-2021-003015

February 23, 2022

Original research
The potential for deprescribing in a palliative oncology patient population: a cross-sectional study

Lisanne N van Merendonk, Bas J M Peters, Julia E Möhlmann, Cornelis B Hunting, Elisabeth A Kastelijn, Marcel P H van den Broek

doi: 10.1136/ejhpharm-2021-003143

February 17, 2022

Original research
Analysis of medication-related triggers to determine adverse drug events

Melissa Augustino, Meghan Rowcliffe, Agnes Feemster, Jacob Smith, Rosemary Duncan

doi: 10.1136/ejhpharm-2021-003078

February 10, 2022

Original research
Potential costs and consequences associated with medication error at hospital discharge: an expert judgement study

Grainne Kirwan, Aisling O’Leary, Cathal Walsh, Robert Briggs, Victoria Robinson, Radzi Rodzlan, Patrick Redmond, Tamasine Grimes

doi: 10.1136/ejhpharm-2021-002697

February 01, 2022

Original research
Paediatric capsule compounding in hospital practices: by weight or by volume?

Maya Wasilewski, Christophe Curti, Cyrielle Bouguergour, Camille Panuccio, Patrick Thevin, Nicolas Primas, Edouard Lamy, Patrice Vanelle

doi: 10.1136/ejhpharm-2021-003065

January 27, 2022

Original research
Medication reconciliation—is it possible to speed up without compromising quality? A before–after study in the emergency department

Monica Hermann, Markus Dreetz Holt, Reidun L S Kjome, Arna Teigen

doi: 10.1136/ejhpharm-2021-003071
Original research
Primary care electronic medication record discrepancies in patients starting treatment at a hospital-based ambulatory care pharmacy and impact on prevalence of potential drug–drug interactions

Elena González-Colominas, Carlos López-Mula, Javier Martínez-Casanova, Sonia Luque, David Conde-Estévez, Inés Monge-Escartín, Olivia Ferrández

doi: 10.1136/ejhpharm-2021-002963
Case report
Dl-3-n-butylphthalide induced anaphylactic shock: a case report

Wanting Huang, Liezhen Cao, Ling Ding, Xiaoyan He

doi: 10.1136/ejhpharm-2021-003124

January 21, 2022

Letter
Defining innovativeness of high-technology medical devices in an Italian region

Andrea Messori, Sabrina Trippoli, Laura Bartoli, Claudio Marinai

doi: 10.1136/ejhpharm-2021-003204

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

August 12, 2022

August 08, 2022

July 26, 2022

July 19, 2022

July 07, 2022

July 06, 2022

June 22, 2022

June 21, 2022

June 15, 2022

June 09, 2022

June 02, 2022

May 23, 2022

May 19, 2022

May 06, 2022

May 02, 2022

April 20, 2022

April 15, 2022

April 12, 2022

April 11, 2022

April 05, 2022

March 31, 2022

March 30, 2022

March 24, 2022

March 10, 2022

March 01, 2022

February 28, 2022

February 25, 2022

February 23, 2022

February 17, 2022

February 10, 2022

February 01, 2022

January 27, 2022

January 21, 2022

Pages